CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
BiPAP autoSV Advanceddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01199042
NCT01199042N/ACompleted

BiPAP (Automatic Servo Ventilation) autoSV Advanced in Central Apnea Patients

Philips Respironics·interventional·Posted Sep 10, 2010·Updated Apr 28, 2016

In Brief

A clinical study evaluating BiPAP autoSV Advanced for Cheyne-Stokes Respiration and Sleep Apnea, Central. Completed, enrolled 29 participants across 3 sites.

Detailed Summary

Pilot study testing the Bipap autoSV Advanced Algorithm during full night, in-lab polysomnography (PSG) and 3 months at home on patients with Central Sleep Apnea, Hunter Cheyne Stokes Respiration, or Complex Sleep Apnea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 10, 2010
Enrollment StartSep 1, 2010
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 15.8 years ago

Interventions

BiPAP autoSV Advanceddevice

The sleep apnea device will be set-up in automatic mode with the settings wide open for the entire night.